Microbial exopolysaccharides in the biomedical and pharmaceutical industries
Ashwini A. Waoo,
Sukhendra Singh,
Ashutosh Pandey,
Gaurav Kant,
Kamlesh Choure,
Kassian T.T. Amesho,
Sameer Srivastava
Affiliations
Ashwini A. Waoo
Department of Biotechnology, AKS University, Satna, India
Sukhendra Singh
Department of Biotechnology, Institute of Applied Sciences and Humanities, GLA University, Mathura, India
Ashutosh Pandey
Department of Biotechnology, AKS University, Satna, India; Institute for Water and Wastewater Technology, Durban University of Technology, Durban, South Africa; Corresponding author. Institute for Water and Wastewater Technology, Durban University of Technology, Durban, South Africa
Gaurav Kant
Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Prayagraj, India
Kamlesh Choure
Department of Biotechnology, AKS University, Satna, India
Kassian T.T. Amesho
Institute of Environmental Engineering, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Center for Emerging Contaminants Research, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; The International University of Management, Centre for Environmental Studies, Main Campus, Dorado Park Ext 1, Windhoek, Namibia; Destinies Biomass Energy and Farming Pty Ltd, P.O. Box 7387, Swakomund, Namibia; Corresponding author. Institute of Environmental Engineering, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Sameer Srivastava
Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Prayagraj, India
The most significant and renewable class of polymeric materials are extracellular exopolysaccharides (EPSs) produced by microorganisms. Because of their diverse chemical and structural makeup, EPSs play a variety of functions in a variety of industries, including the agricultural industry, dairy industry, biofilms, cosmetics, and others, demonstrating their biotechnological significance. EPSs are typically utilized in high-value applications, and current research has focused heavily on them because of their biocompatibility, biodegradability, and compatibility with both people and the environment. Due to their high production costs, only a few microbial EPSs have been commercially successful. The emergence of financial barriers and the growing significance of microbial EPSs in industrial and medical biotechnology has increased interest in exopolysaccharides. Since exopolysaccharides can be altered in a variety of ways, their use is expected to increase across a wide range of industries in the coming years. This review introduces some significant EPSs and their composites while concentrating on their biomedical uses.
